Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis
Xu Hu,*,1 Yan Wang,*,1 Wei-Xiao Yang,*,1 Wei-Chao Dou,1 Yan-Xiang Shao,1 Xiang Li21West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China; 2Department of Urology, West China Hospital, West China Medical School, Sichuan University,...
Main Authors: | Hu X, Wang Y, Yang WX, Dou WC, Shao YX, Li X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/modified-glasgow-prognostic-score-as-a-prognostic-factor-for-renal-cel-peer-reviewed-article-CMAR |
Similar Items
-
A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
by: Tongyu Tong, et al.
Published: (2020-09-01) -
Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
by: Lu X, et al.
Published: (2018-12-01) -
Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis
by: Daqing Tan, et al.
Published: (2022-10-01) -
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
by: Yongchao Zhang, et al.
Published: (2023-01-01) -
Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
by: Kenta Kasahara, et al.
Published: (2022-01-01)